Humacyte, Inc. (NASDAQ:HUMA) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 17, 2026, Humacyte, Inc.
Engineered tissue could eventually be used for children born with gaps in their alimentary canal, or for adults whose muscles ...
Purchase commitment is for a minimum of $1.475 million of Symvess product -DURHAM, N.C., March 19, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform ...
Net proceeds from the offering will fund the commercialization of Symvess® in the vascular trauma indication and provide funding beyond key milestones such as the upcoming read-out of Phase 3 results ...
Science fiction gets a bad rep for being obsessed with distant futures full of spaceships, robots, and aliens. The genre ...
A new bioengineered neuronal circuit board "BioConNet" allows scientists to artificially engineer human brain-like wiring at scale and can be used to engineer any possible circuit. The fully ...
Humacyte is also pursuing a mechanism for making Symvess available in Israel on a hospital-by-hospital basis in advance of MAA approval - - ...
In this article, we will look at the 11 Best High Volume Penny Stocks to Buy Now. After a prolonged period where mega-cap ...
(Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company’s management ...
Glyphosate is a broad-spectrum systemic herbicide and crop desiccant that has been used for decades. However, glyphosate is a ...
Tiny shards of plastic called microplastics are all over the environment and even inside human bodies. Researchers have found a type of bioengineered algae that can clean up these pesky particles.